Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
dose delay
Description:
A postponement of a scheduled medication or treatment dose, often resulting from toxicity, recovery needs, or clinical circumstances.
Related topics:
Neutropenia and Cancer Infections (18%),
Breast Cancer Treatment Studies (12%)
OpenAlex ID:
keywords/dose-delay
Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
2010
·
J Bray
, J Sludden
, et al.
·
British Journal of Cancer
·
199
PDF
Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer
2008
·
Joseph A. Greer
, William F. Pirl
, et al.
·
Journal of Psychosomatic Research
·
188
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
2020
·
Gary Middleton
, Kristian Brock
, et al.
·
The Lancet Respiratory Medicine
·
178
Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study
2010
·
Isamu Okamoto
, Hiroshige Yoshioka
, et al.
·
Journal of Clinical Oncology
·
175
Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
2013
·
Rebecca M. Speck
, Mary D. Sammel
, et al.
·
Journal of Oncology Practice
·
154
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study
2021
·
Sagar Lonial
, Hans C. Lee
, et al.
·
Cancer
·
152
Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
2006
·
Michelle Shayne
, Jeffrey Crawford
, et al.
·
Breast Cancer Research and Treatment
·
152
Chemotherapy dose reduction and delay in clinical practice
2000
·
J Chang
·
European Journal of Cancer
·
128
Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
2011
·
Sibylle Loibl
, Tomas Skacel
, et al.
·
BMC Cancer
·
127
PDF
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
2010
·
P. Wheatley-Price
, F. Blackhall
, et al.
·
Annals of Oncology
·
123
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer
2019
·
Michael A. Morse
, Michael J. Overman
, et al.
·
The Oncologist
·
116
PDF
Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients
2003
·
on behalf of the UK Breast Cancer Neutropenia Audit Group
, R C F Leonard
, et al.
·
British Journal of Cancer
·
107
PDF
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer
2018
·
Neelima Denduluri
, Gary H. Lyman
, et al.
·
Clinical Breast Cancer
·
99
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
2019
·
Jeffrey Crawford
, Neelima Denduluri
, et al.
·
Supportive Care in Cancer
·
80
PDF
Avaliação de coberturas vacinais de crianças em uma cidade de médio porte (Brasil) utilizando registro informatizado de imunização
2018
·
Vinicius Leati de Rossi Ferreira
, Eliseu Alves Waldman
, et al.
·
Cadernos de Saúde Pública
·
79
PDF
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
2012
·
Derek Weycker
, Rich Barron
, et al.
·
Breast Cancer Research and Treatment
·
78
Chemotherapy dose intensity and quality cancer care.
2006
·
Gary H Lyman
·
PubMed
·
75
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study
2010
·
Matthias Schwenkglenks
, Ruth Pettengell
, et al.
·
Supportive Care in Cancer
·
74
Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial
2016
·
Werner Scheithauer
, Ramesh K. Ramanathan
, et al.
·
Journal of Gastrointestinal Oncology
·
72
PDF
Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose Regimen
1989
·
D. R. Gandara
, H. Wold
, et al.
·
JNCI Journal of the National Cancer Institute
·
72
Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study
2017
·
Allison Magnuson
, Tatyana Lemelman
, et al.
·
Supportive Care in Cancer
·
71
Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
2021
·
Daniel L. Hertz
, Daniel S. Childs
, et al.
·
Cancer Treatment Reviews
·
68
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
2010
·
Ron J. Keizer
, Anubha Gupta
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
67
PDF
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
2016
·
S. Lonardi
, A. Sobrero
, et al.
·
Annals of Oncology
·
65
PDF
Chemotherapy interruptions in relation to symptom severity in advanced breast cancer
2015
·
Gwen Wyatt
, Alla Sikorskii
, et al.
·
Supportive Care in Cancer
·
60
Show more works
View as search
Works count:
299
Citation count:
4,556
Year
Topic
Type